10x Genomics, Inc. is trading at $29.84 (down 2.44%), easing after a sharp rally triggered by its announced acquisition of Proteintech Genomics.
- The pullback represents a partial giveback of the 4.83% gain recorded on June 9, 2026, following the M&A announcement.
- Today's price action appears driven by a mildly weaker, risk-off environment for U.S. equities rather than new company-specific developments.
- Shares remain higher than pre-announcement levels as investors continue to weigh the impact of the strategic acquisition.